Other

Novo Nordisk reports profit rise, progress on US drug permit

The world's top insulin maker, Novo Nordisk, reported rising quarterly profits on Thursday and said studies required to release long-acting insulin Tresiba in the US would be completed sooner than previously thought.

Medications

Pfizer to pay $35M to settle drug marketing case

Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses.

Diseases, Conditions, Syndromes

300 vials labeled flu, dengue found at US lab (Update)

The same U.S. government scientist who recently found forgotten samples of smallpox at a federal lab also uncovered over 300 additional vials, many bearing the names of highly contagious viruses and bacteria. The new revelations ...

Oncology & Cancer

FDA weighs cancer risk of fibroid removal devices

Federal health advisers say there is little to no evidence that a popular technique for removing fibroids can be performed without the risk of spreading undetected cancers to other parts of the body.

Oncology & Cancer

Patients seek US ban on fibroid removal devices

More than a dozen Americans—including cancer patients, their family members and physicians—called on U.S. health regulators on Friday to block the use of electronic surgical tools used to remove fibroids, but which can ...

page 20 from 40